Overlooked Drug Could Save Thousands Of Moms After Childbirth
An inexpensive drug could dramatically reduce the number of deaths of mothers from bleeding after childbirth in low- and middle-income countries around the world.
Pharmaceuticals
Nonprofit Working To Block Drug Imports Has Ties To Pharma Lobby
An organization campaigning against foreign drug imports has deep connections to the lobbying group PhRMA, which includes Eli Lilly, Pfizer and Bayer, an analysis by Kaiser Health News reveals.
Taking Shortcuts In Drug Testing Can Put Patients At Risk
Researchers use intermediate endpoints like how a drug lowers cholesterol to get a quick sense of whether the drug might improve health. But those shortcuts often don't show true benefits and harms.
Trump Chooses Dr. Scott Gottlieb To Head Food And Drug Administration
Gottlieb is seen as a mainstream pick for an agency that oversees a quarter of the U.S. economy, including pharmaceuticals, medical devices, food, cosmetics and other areas of human and animal health.
Sen. Grassley Launches Inquiry Into Orphan Drug Law's Effect On Prices
Citing a Kaiser Health News investigation, Sen. Chuck Grassley, chairman of the Senate Judiciary Committee, will examine potential abuses of incentives to spur development of drugs for rare diseases.
How A Simple Fix For Medicare Prescribing Problems Got Complicated
In 2014, the government said health providers would have to register with Medicare in order to prescribe drugs to beneficiaries. Delays have pushed back the requirement until 2019.
Drug Distributors Penalized For Turning Blind Eye In Opioid Epidemic
The wholesalers that move medicines between drug companies and pharmacies have been fined for failing to call out suspicious transactions involving opioids.
6 Senators Assessing Trump's HHS Nominee Own Health Care Stocks, Too
A half-dozen senators involved in confirmation hearings for Rep. Tom Price to head the Department of Health and Human Services have health care investments made by themselves or family members.
From Twitter To Treatment Guidelines, Industry Influence Permeates Medicine
Several new studies document widespread conflicts of interest in medicine. The way we think about disease "is being subtly distorted" by financial ties, the authors of an accompanying editorial write.
Drugs For Rare Diseases Have Become Uncommonly Rich Monopolies
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives by doing so. But nearly a third of the medicines aren't new or were repurposed many times for financial gain.